DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Ichikawa H, Sugimoto M, Sugimoto K. et al.
Rapid metabolizer genotype of CYP 2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis.
J Gastroenterol Hepatol 2016;
31: 716-726
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.